NCT01897259

Brief Summary

This is a prospective study where patients with lateral epicondylitis (tennis elbow) will be randomized into one of 4 possible treatments. The purpose is to individually examine the efficacy of each treatment, and determine if one treatment method is more effective than another. The four treatments are: corticosteriod injections, prolotherapy, NSAIDs (non-steroidal anti-inflammatory drugs) combined with physical therapy, and a placebo.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2012

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2012

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

July 11, 2013

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

January 25, 2018

Status Verified

January 1, 2018

Enrollment Period

7.3 years

First QC Date

June 11, 2012

Last Update Submit

January 23, 2018

Conditions

Keywords

tennis elbowlateral epicondylitis

Outcome Measures

Primary Outcomes (2)

  • Symptom Severity in pre intervention assessments

    12 months

  • Symptom severity in post-intervention assessments

    12 months

Secondary Outcomes (2)

  • Functional status score pre-intervention

    12 months

  • Functional status score severity- post intervention

    12 months

Study Arms (4)

Corticosteroid Injections

ACTIVE COMPARATOR

Patients will receive 1 cc Kenalong 10 mg injection to the site every 6 weeks until clinical symptoms have resolved. They will also receive an anesthetic of 1cc 1% lidocaine in conjunction with the corticosteroid injection.

Drug: Corticosteroid Injections

Prolotherapy

ACTIVE COMPARATOR

Participants receive 1cc 50% Dextrose and 1 cc Sodium Morrhuate to the site every 6 weeks until symptoms resolve. These participants will also receive an anesthetic of 1cc 1% lidocaine.

Drug: Prolotherapy

Placebo

PLACEBO COMPARATOR

Participants will recieve placebo injections (1cc 1% lidocaine and 1cc normal saline).

Drug: Placebo Injection

Physical Therapy

ACTIVE COMPARATOR

Participants will be prescribed NSAIDS (Diclofenac 75 mg BID) for 2 weeks. Participants will attend therapy for muscle stretches, soft tissue mobilization, and gradual strengthening.

Behavioral: Physical Therapy

Interventions

Participants in the placebo group will recieve placebo injections (1cc 1% lidocaine and 1cc normal saline).

Placebo

Subjects participating in the physical therapy group will attend physical therapy and be prescribed to NSAIDS. No prolotherapy or corticosteroid injections.

Physical Therapy

Participants in the corticosteroid group will recieve corticosteroid injections (1 cc Kenalog 10 mg). They will also recieve anesthetic of 1 ml 1% lidocaine.

Corticosteroid Injections

Subjects participating in the prolotherapy group will recieve 1 cc 50% Dextrose and Sodium Morrhuate 1 cc injections.

Prolotherapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pain over the lateral epicondyle (via palpation over the lateral epicondyle, resisted wrist extension, resisted finger extension of the middle finger) for less than six-months duration prior to enrollment
  • conservative treatment of tennis elbow is recommended as standard of care treatment
  • over the age of 18 and under the age of 65
  • ability to give informed consent

You may not qualify if:

  • treatment by a health care profession (MD, physicians assistnat, therapist, or nurse practitioner) within the previous 6 months for tennis elbow
  • congenital deformities, tendon ruptures, or fractures of the elbow within the previous 12 months
  • immobility casts or splints within the last 6 months for tennis elbow
  • co-existing elbow diagnosis (i.e. osteoarthritis or instability)
  • pregnant women, women trying to get pregnant, or breastfeeding women
  • under the age of 18 or over the age of 65

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Christine M. Kleinert Institute of Hand and Microsurgery

Louisville, Kentucky, 40202, United States

RECRUITING

MeSH Terms

Conditions

Tennis Elbow

Interventions

Physical Therapy ModalitiesProlotherapy

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationComplementary Therapies

Study Officials

  • Tuna Ozyurekoglu, MD

    Christine M. Kleinert Institute for Hand and Microsurgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Millicent L Horn, BS

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2012

First Posted

July 11, 2013

Study Start

March 1, 2012

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

January 25, 2018

Record last verified: 2018-01

Locations